Literature DB >> 10675708

Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration.

G M El Maghraby1, A C Williams, B W Barry.   

Abstract

The aims of this study were to refine ultradeformable liposomes for oestradiol skin delivery and to evaluate Span 80 and Tween 80 as edge activators compared with sodium cholate. Vesicles containing phosphatidylcholine (PC) mixed with edge activators and oestradiol were prepared. Entrapment efficiency and vesicle size were determined. Interactions between activators and vesicles were investigated using differential scanning calorimetry. Transepidermal permeation of oestradiol from vesicles was studied compared to saturated aqueous control in vitro. The maximum flux (J(max)) and its time (T(max)) were calculated from the flux curves and skin deposition was assessed. The compositions of refined formulations were predicted, liposomes prepared, and tested against control. Entrapment efficiency depended on PC concentration with some contribution from sodium cholate and Tween 80. Vesicle sizes ranged from 124 to 135 nm. Edge activators interacted with lipid bilayers and disrupted packing. The refined edge activator concentrations in PC vesicles were 14.0, 13.3 and 15.5% w/w for sodium cholate, Span 80 and Tween 80, respectively; they increased J(max) by 18, 16 and 15-fold and skin deposition by 8, 7 and 8-fold compared with control. Ultradeformable vesicles thus improved skin delivery of oestradiol compared to control and Span 80 and Tween 80 were equivalent to sodium cholate as edge-activators.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10675708     DOI: 10.1016/s0378-5173(99)00441-x

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  36 in total

1.  Drug-cyclodextrin-vesicles dual carrier approach for skin targeting of anti-acne agent.

Authors:  Navjot Kaur; Richa Puri; Subheet Kumar Jain
Journal:  AAPS PharmSciTech       Date:  2010-03-24       Impact factor: 3.246

2.  Proultraflexible lipid vesicles for effective transdermal delivery of levonorgestrel: development, characterization, and performance evaluation.

Authors:  Subheet Jain; Rachna Sapre; Ashok K Tiwary; Narendra K Jain
Journal:  AAPS PharmSciTech       Date:  2005-10-24       Impact factor: 3.246

3.  Evaluation of meloxicam-loaded cationic transfersomes as transdermal drug delivery carriers.

Authors:  Sureewan Duangjit; Praneet Opanasopit; Theerasak Rojanarata; Tanasait Ngawhirunpat
Journal:  AAPS PharmSciTech       Date:  2012-12-14       Impact factor: 3.246

4.  Nanocarriers to Enhance the Accumulation of Vitamin K1 into the Skin.

Authors:  Virginia Campani; Marco Biondi; Laura Mayol; Francesco Cilurzo; Silvia Franzé; Michele Pitaro; Giuseppe De Rosa
Journal:  Pharm Res       Date:  2015-11-30       Impact factor: 4.200

5.  Transcutaneous immunization studies in mice using diphtheria toxoid-loaded vesicle formulations and a microneedle array.

Authors:  Zhi Ding; Suzanne M Bal; Stefan Romeijn; Gideon F A Kersten; Wim Jiskoot; Joke A Bouwstra
Journal:  Pharm Res       Date:  2010-03-17       Impact factor: 4.200

6.  Ultraflexible lipid vesicles allow topical absorption of cyclosporin A.

Authors:  Juan J Carreras; Willian E Tapia-Ramirez; Adrian Sala; Antonio J Guillot; Teresa M Garrigues; Ana Melero
Journal:  Drug Deliv Transl Res       Date:  2020-04       Impact factor: 4.617

Review 7.  Transdermal drug delivery of insulin with ultradeformable carriers.

Authors:  Gregor Cevc
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

8.  Hydroxyzine from topical phospholipid liposomal formulations: evaluation of peripheral antihistaminic activity and systemic absorption in a rabbit model.

Authors:  Abeer A W Elzainy; Xiaochen Gu; F Estelle R Simons; Keith J Simons
Journal:  AAPS PharmSci       Date:  2003-11-05

9.  Transdermal delivery of pergolide from surfactant-based elastic and rigid vesicles: characterization and in vitro transport studies.

Authors:  P Loan Honeywell-Nguyen; Peter M Frederik; Paul H H Bomans; Hans E Junginger; Joke A Bouwstra
Journal:  Pharm Res       Date:  2002-07       Impact factor: 4.200

10.  Skin penetration and mechanisms of action in the delivery of the D2-agonist rotigotine from surfactant-based elastic vesicle formulations.

Authors:  P Loan Honeywell-Nguyen; Sonia Arenja; Joke A Bouwstra
Journal:  Pharm Res       Date:  2003-10       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.